{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:33:22Z","timestamp":1780086802144,"version":"3.54.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.vaccine.2015.05.106","type":"journal-article","created":{"date-parts":[[2015,7,16]],"date-time":"2015-07-16T16:40:05Z","timestamp":1437064805000},"page":"6099-6105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Seasonal split influenza vaccine induced IgE sensitization against influenza vaccine"],"prefix":"10.1016","volume":"33","author":[{"given":"Tetsuo","family":"Nakayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuji","family":"Kumagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruo","family":"Okafuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eitaro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.05.106_bib0210","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/pds.998","article-title":"A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)\u2014United States, 1991\u20132001","volume":"13","author":"Zhou","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0215","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jclinepi.2005.11.012","article-title":"Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations","volume":"59","author":"Glanz","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0220","doi-asserted-by":"crossref","first-page":"5975","DOI":"10.1016\/j.vaccine.2013.10.031","article-title":"Evaluating the safety of influenza vaccine using a claims-based health system","volume":"31","author":"McCarthy","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0225","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.1016\/j.vaccine.2010.04.041","article-title":"Brighton Collaboration Working Group on anaphylaxis can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study","volume":"28","author":"Gold","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0230","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1016\/j.vaccine.2014.04.070","article-title":"An algorithm developed using the Brighton Collaboration case definitions is more efficient for determining diagnostic certainty","volume":"32","author":"Joshi","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0235","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0091-6749(76)90095-6","article-title":"Egg allergy, influenza vaccine, and immunoglobulin E antibody","volume":"57","author":"Davies","year":"1976","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0240","first-page":"191","article-title":"Vaccinations of children allergic to eggs with vaccine prepared with egg","volume":"50","author":"Tounian","year":"1993","journal-title":"Arch Fr Pediatr"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0245","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/j.1365-2222.2011.03842.x","article-title":"Influenza immunization in egg allergy: an update for the 2011\u20132012 season","volume":"41","author":"Erlewyn-Lajeunesse","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0250","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.jaci.2010.03.009","article-title":"Ovalbumin content of influenza vaccines","volume":"125","author":"Li JT","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0255","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0022-3476(98)70101-5","article-title":"Safe administration of influenza vaccine to patients with egg allergy","volume":"133","author":"James","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0260","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.aller.2013.03.005","article-title":"Food Allergy Committee of SEICAP. Position document: IgE-mediated allergy to egg protein","volume":"41","author":"Martorell","year":"2013","journal-title":"Allergol Immunopathol"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0265","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3928\/00904481-20130619-09","article-title":"Establishing the safety of influenza vaccine in egg-allergic individuals","volume":"42","author":"Greenhawt","year":"2013","journal-title":"Pediatr Ann"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0270","doi-asserted-by":"crossref","first-page":"50","DOI":"10.7774\/cevr.2014.3.1.50","article-title":"Vaccine allergies","volume":"3","author":"Chung","year":"2014","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0275","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1586\/14760584.2014.933079","article-title":"Administering influenza vaccine to egg-allergic persons","volume":"13","author":"Kelso","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0280","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1016\/j.vaccine.2013.10.033","article-title":"Increased risk of anaphylaxis following administration of 2009 AS03 \u2013 adjuvanted monovalent pandemic A\/H1N1 (H1N1pdm09) vaccine","volume":"31","author":"Rouleau","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0285","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1016\/j.vaccine.2013.09.066","article-title":"Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: reports to VAERS","volume":"31","author":"Halsey","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0290","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2165\/11539270-000000000-00000","article-title":"Monitoring adverse events of the vaccination campaign against influenza A (H1N1) in the Netherlands","volume":"33","author":"van Puijenbroek","year":"2010","journal-title":"Drug Saf"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0295","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jaci.2010.10.015","article-title":"Administration of influenza vaccines to patients with egg allergy: update for the 2010\u20132011 season","volume":"126","author":"Kelso","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0300","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S1081-1206(10)61024-1","article-title":"Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions","volume":"95","author":"Coors","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0305","unstructured":"Safety information from Pharmaceuticals and Medical Devices Agency (PMDA), No.294, \u3008http:\/\/www1.mhlw.go.jp\/kinkyu\/iyaku_j\/iyaku_j\/anzenseijyouhou\/294-2.pdfI.\u3009 Sep. 2012."},{"key":"10.1016\/j.vaccine.2015.05.106_bib0310","unstructured":"Report on the anaphylaxis following vaccination with influenza HA vaccine from The Chemo-Sero-Therapeutic Research Institute, \u3008http:\/\/www.mhlw.go.jp\/stf\/shingi\/2r9852000002c06s-att\/2r9852000002c0cb.pdf.\u3009"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0315","doi-asserted-by":"crossref","DOI":"10.1089\/vim.2014.0010","article-title":"Humoral immune response to influenza A(H1N1)pdm2009 in patients with natural infection and in vaccine recipients in the 2009 pandemic","author":"Kumagai","year":"2014","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0325","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0091-6749(96)80191-6","article-title":"Food allergy to gelatin in children with systemic immediate-type reactions, including anaphylaxis, to vaccines","volume":"98","author":"Sakaguchi","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0330","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0091-6749(99)70508-7","article-title":"A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids","volume":"103","author":"Nakayama","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0335","doi-asserted-by":"crossref","unstructured":"Nakayama T, Aizawa C. Change in gelatin content of vaccines associated with reduction in reports of allergic reactions. J Allergy Clin Immunol 200; 106:591\u20132.","DOI":"10.1067\/mai.2000.108433"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0340","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.vaccine.2006.05.130","article-title":"Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004","volume":"25","author":"Nakayama","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0345","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1620\/tjem.232.97","article-title":"Effectiveness of trivalent influenza vaccine among children in two consecutive seasons in a community in Japan","volume":"232","author":"Suzuki","year":"2014","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0350","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.4049\/jimmunol.1003126","article-title":"MAPK kinase 3 specifically regulates FcRI-mediated IL-4 production by mast cells","volume":"187","author":"MacNeil","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0355","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2147\/JIR.S34152","article-title":"Long-term persistence of IgE anti-influenza A H1N1 virus antibodies in serum of children and adults following Influenza A vaccination with subsequent H1N1 infection: a case study","volume":"5","author":"Smith-Norowitz","year":"2012","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0360","doi-asserted-by":"crossref","first-page":"239","DOI":"10.7150\/ijms.8.239","article-title":"Long term persistence of IgE anti-influenza virus antibodies in pediatric and adult serum post vaccination with influenza virus vaccine","volume":"8","author":"Smith-Norowitz","year":"2011","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0365","first-page":"85","article-title":"Anaphylaxis from influenza virus vaccine","volume":"146","author":"Coop","year":"2008","journal-title":"Novel Insights Clin Pract"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0370","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.jaci.2012.07.019","article-title":"Allergic symptoms after pandemic influenza vaccination rarely mediated by vaccine-specific IgE","volume":"130","author":"Rouleau","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0375","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.immuni.2010.10.007","article-title":"Designing vaccines based on biology of human dendritic cell subsets","volume":"33","author":"Palucka","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0380","series-title":"Vaccine immunology. Vaccines","first-page":"14","author":"Siegrist","year":"2013"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0385","doi-asserted-by":"crossref","first-page":"7662","DOI":"10.1016\/j.vaccine.2012.10.006","article-title":"Alum-adjuvanted H5N1 whole virion inactivated vaccine (WIV) induced IgG1 and IgG4 antibody responses in young children","volume":"30","author":"Nakayama","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0390","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/gene.2014.45","article-title":"Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-\u03b2","volume":"15","author":"Palomares","year":"2014","journal-title":"Genes Immun"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0395","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fimmu.2013.00152","article-title":"Generation and function of induced regulatory T cells","volume":"4","author":"Schmitt","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0400","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaci.2013.12.1088","article-title":"Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to antigens","volume":"133","author":"Akdis","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0405","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.4161\/hv.21117","article-title":"The regulatory T cells in anti-influenza antibody response post influenza vaccination","volume":"9","author":"Wang","year":"2012","journal-title":"Hum Vaccine Immunother"},{"key":"10.1016\/j.vaccine.2015.05.106_bib0410","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/cid\/ciu948","article-title":"Allergic reactions after egg-free recombinant influenza vaccine: reports to the US Vaccine Adverse Event Reporting System","volume":"60","author":"Woo","year":"2015","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15009123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15009123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T22:51:53Z","timestamp":1537483913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15009123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":40,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0264410X15009123"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.05.106","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seasonal split influenza vaccine induced IgE sensitization against influenza vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.05.106","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}